Oncology Activities
Managed Care Strategies to Support Access to CAR T-Cell Therapy
0290-0000-21-081-L01-P
This live webinar will examine recent studies for approved and emerging chimeric antigen receptor-modified T cell (CAR T-cell) therapies and the impact of these treatments on the future paradigm of cancer care.
5-11-2021
1.00
Continuing the Conversation | HER2+ Metastatic Breast Cancer and What Targeted Therapy Means for Managed Care
0290-0000-21-003-H01-P
This CE accredited article will analyze evolving guideline recommendations for patient management in the treatment of HER2+ metastatic breast cancer
1.00
Immune Checkpoint Inhibitor/Chemotherapy Combinations for Metastatic Triple-Negative Breast Cancer: Emerging Clinical Data and Managed Care Considerations
0290-0000-21-036-H01-P
This activity will determine the biological rationale for available and emerging treatment strategies involving immune checkpoint inhibitor (ICI)/chemotherapy combinations for the treatment of metastatic triple-negative breast cancer (mTNBC)
1.50
New and Emerging Management Strategies for Acute Graft-Versus-Host Disease in Hematopoietic Stem Cell Transplant
0290-0000-21-026-H01-P
This activity will review clinical data for new and emerging strategies in aGVHD prevention and treatment, the role of biomarkers, and the role of the pharmacist in patient care.
1.50